“Pneumonia of unknown cause – China.” https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON229 (accessed May 11, 2023).

“Archived: WHO Timeline – COVID-19.” https://www.who.int/news/item/27-04-2020-who-timeline---covid-19 (accessed May 11, 2023).

“Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV).” https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (accessed May 11, 2023).

W. Bian, “Autopsy of COVID-19 patients in China,” Natl Sci Rev, vol. 7, no. 9, pp. 1414–1418, Sep. 2020, doi: 10.1093/NSR/NWAA123.  

G. Menezes, T. Rizwan, S. S. Ali, W.Hassan et al., “Postmortem findings in COVID-19 fatalities: A systematic review of current evidence,” Leg Med (Tokyo), vol. 54, p. 102001, Feb. 2022, doi: 10.1016/J.LEGALMED.2021.102001.

Wichmann, J. P. Sperhake, M. Lutgehetmann, S. Steurer et al., “Autopsy Findings and Venous Thromboembolism in Patients With COVID-19,” 10.7326/M20-2003, vol. 173, no. 4, pp. 268–277, May 2020, doi: 10.7326/M20-2003.

“The true death toll of COVID-19: estimating global excess mortality.” https://www.who.int/data/stories/the-true-death-toll-ofcovid-19-estimating-global-excess-mortality (accessed May 09, 2023).

Checchi and L. Roberts, “Interpreting and Using Humanitarian Mortality Data in Humanitarian Emergencies. A primer for non-epidemiologists,” 2005, Accessed: May 11, 2023. [Online]. Available: www.ennonline.net/mortalitydataprimer

Shang, Y. Wang, J. Yuan, Z. Guo et al., “Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis,” Vaccines (Basel), vol. 10, no. 10, Oct. 2022, doi: 10.3390/VACCINES10101702.

Karanikolos and M. Mckee, “HOW COMPARABLE IS COVID-19 MORTALITY ACROSS COUNTRIES?,” Eurohealth (Lond), vol. 26, no. 2, 2020.

Islam, “‘Excess deaths’ is the best metric for tracking the pandemic,” BMJ, vol. 376, 2022.

Cruz-Cano and E. L. Mead, “Excess Deaths After Hurricane Maria in Puerto Rico,” JAMA, vol. 321, no. 10, p. 1005, Mar. 2019, doi: 10.1001/JAMA.2018.20861.

Dahal, M. Jenner, L. Dinh, K. Mizumoto et al., “Excess mortality patterns during 1918-1921 influenza pandemic in the state of Arizona, USA,” Ann Epidemiol, vol. 28, no. 5, pp. 273–280, May 2018, doi: 10.1016/J.ANNEPIDEM.2017.12.005.

P. A. Ioannidis, “Over- and under-estimation of COVID-19 deaths,” Eur J Epidemiol, vol. 36, no. 6, p. 581, Jun. 2021, doi: 10.1007/S10654-021-00787-9.

O’Driscoll, G. R. dos Santos, L. Wang, D. A. T. Cummings et al., “Age-specific mortality and immunity patterns of SARS-CoV-2,” Nature, vol. 590, no. 7844, pp. 140–145, Feb. 2021, doi: 10.1038/S41586-020-2918-0.

Horton, “Offline: COVID-19 is not a pandemic,” Lancet, vol. 396, no. 10255, p. 874, Sep. 2020, doi: 10.1016/S0140-6736(20)32000-6.

“Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21,” Lancet, vol. 399, no. 10334, pp. 1513–1536, Apr. 2022, doi: 10.1016/S0140-6736(21)02796-3.

“14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021.” https://www.who.int/news/item/05-05-2022-14.9-million-excess-deaths-were-associated-with-the-covid-19-pandemic-in-2020-and-2021 (accessed May 12, 2023).

Excess mortality – statistics – Statistics Explained.” https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Excess_mortality_-_statistics#Excess_mortality_in_the_EU_between_January_2020_and_February_2023 (accessed May 12, 2023).

Achilleos, A. Quattrocchi, J. Gabel, A. Heraclides et al., “Excess all-cause mortality and COVID-19-related mortality: a temporal analysis in 22 countries, from January until August 2020,” Int J Epidemiol, vol. 51, no. 1, pp. 35–53, 2022, doi: 10.1093/IJE/DYAB123.

Li, S. Pei, B. Chen, Y. Song et al., “Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2),” Science, vol. 368, no. 6490, p. 489, May 2020, doi: 10.1126/SCIENCE.ABB3221.

Rothe, M. Schunk, P. Sothmann, G. Bretzel et al., “Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany,” New England Journal of Medicine, vol. 382, no. 10, pp. 970–971, Mar. 2020, doi: 10.1056/NEJMC2001468.

Álvarez, L. Orea, and A. Wall, “Estimating the propagation of both reported and undocumented COVID-19 cases in Spain: a panel data frontier approximation of epidemiological models,” Journal of Productivity Analysis, vol. 59, no. 3, p. 259, Jun. 2023, doi: 10.1007/S11123-023-00664-5.

K. Biswas, A. Afiaz, and S. Huq, “Underreporting COVID-19: the curious case of the Indian subcontinent,” Epidemiol Infect, vol. 148, 2020, doi: 10.1017/S0950268820002095.

Kupek, “How many more? Under-reporting of the COVID-19 deaths in Brazil in 2020,” Trop Med Int Health, vol. 26, no. 9, pp. 1019–1028, Sep. 2021, doi: 10.1111/TMI.13628.

N. Y. Tsang, H. C. So, K. Y. Ng, B. J. Cowling et al., “Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis,” Lancet Infect Dis, vol. 21, no. 9, pp. 1233–1245, Sep. 2021, doi: 10.1016/S1473-3099(21)00146-8.

Arevalo-Rodriguez, D. Buitrago-Garcia, D. Simancas-Racines, P. Zambrano-Achig et al., “False-negative results of initial RT-PCR assays for COVID-19: A systematic review,” PLoS One, vol. 15, no. 12, p. e0242958, Dec. 2020, doi: 10.1371/JOURNAL.PONE.0242958.

Watson, P. F. Whiting, and J. E. Brush, “Interpreting a covid-19 test result,” BMJ, vol. 369, May 2020, doi: 10.1136/BMJ.M1808.

R. Gill and M. E. Dejoseph, “The Importance of Proper Death Certification during the COVID-19 Pandemic,” JAMA – Journal of the American Medical Association, vol. 324, no. 1, pp. 27–28, Jul. 2020, doi: 10.1001/jama.2020.9536.

Prkachin, “The Reign of the Ventilator: Acute Respiratory Distress Syndrome, COVID-19, and Technological Imperatives in Intensive Care,” Ann Intern Med, vol. 174, no. 8, pp. 1145–1150, Aug. 2021, doi: 10.7326/M21-0270.

Gattinoni, D. Chiumello, P. Caironi, M. Bussana et al., “COVID-19 pneumonia: different respiratory treatments for different phenotypes?,” Intensive Care Med, vol. 46, no. 6, pp. 1099–1102, Jun. 2020, doi: 10.1007/s00134-020-06033-2.

Axfors, A. M. SchmitT, P. Janiaud, J. van’t Hooft et al., “Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials,” Nat Commun, vol. 12, no. 1, Dec. 2021, doi: 10.1038/S41467-021-22446-Z.

Maggialetti, S. Piemonte, E. Sperti, F. Inchingolo et al., “Iatrogenic Barotrauma in COVID-19-Positive Patients: Is It Related to the Pneumonia Severity? Prevalence and Trends of This Complication Over Time,” Biomedicines, vol. 10, no. 10, Oct. 2022, doi: 10.3390/BIOMEDICINES10102493.

“Therapeutics and COVID-19: Living guideline, 13 January 2023.” https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2023.1 (accessed Jul. 02, 2023).

Sanmarchi, D. Golinelli, J. Lenzi, F. Esposito et al., “Exploring the Gap Between Excess Mortality and COVID-19 Deaths in 67 Countries,” JAMA Netw Open, vol. 4, no. 7, pp. e2117359–

Tzankov and D. Jonigk, “Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic,” Virchows Archiv, vol. 477, no. 3, p. 331, Sep. 2020, doi: 10.1007/S00428-020-02887-5.

Salerno, F. Sessa, A. Piscopo, A. Montana et al., “No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science,” J Clin Med, vol. 9, no. 5, May 2020, doi: 10.3390/JCM9051472.

A. Mucheleng’anga, V. Telendiy, A. Hamukale, A. L. Shibemba, et al., “COVID-19 and Sudden Unexpected Community Deaths in Lusaka, Zambia, Africa – A Medico-Legal Whole-Body Autopsy Case Series,” Int J Infect Dis, vol. 109, pp. 160–167, Aug. 2021, doi: 10.1016/J.IJID.2021.07.001.

L. Geller, J. N. Aungst, A. Newtion-Levinson, G. P. Smith et al., “Is it COVID-19? The value of medicolegal autopsies during the first year of the COVID-19 pandemic,” Forensic Sci Int, vol. 330, Jan. 2022, doi: 10.1016/J.FORSCIINT.2021.111106.

V. Siserman, I. I. Jeican, D. Gheban, V. Anton et al., “Fatal Form of COVID-19 in a Young Male Bodybuilder Anabolic Steroid Using: The First Autopsied Case,” Medicina (B Aires), vol. 58, no. 10, Oct. 2022, doi: 10.3390/MEDICINA58101373.

I. B. Lindahl, “COVID-19 and the selection problem in national cause-of-death statistics,” Hist Philos Life Sci, vol. 43, no. 2, Jun. 2021, doi: 10.1007/S40656-021-00420-8.

A. Slater, S. Straw, M. Drozd, S. Kamalathasan et al., “Dying ‘due to’ or ‘with’ COVID-19: a cause of death analysis in hospitalised patients,” Clinical Medicine, vol. 20, no. 5, p. e189, 2020, doi: 10.7861/CLINMED.2020-0440.

Bogdanović, T. Atanasijević, V. Popović, Z.Mihailović et al., “Proper death certification in the time of the COVID-19 pandemic: Forensic perspective,” J Infect Dev Ctries, vol. 16, no. 6, pp. 966–968, Jun. 2022, doi: 10.3855/jidc.16556.

Rao, “Medical certification of cause of death for COVID-19,” Bull World Health Organ, vol. 98, no. 5, May 2020, doi: 10.2471/BLT.20.257600.

Nyberg, N. M. Ferguson, S. G. Nash, H. H. Webster et al., “Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study,” Lancet, vol. 399, no. 10332, pp. 1303–1312, Apr. 2022, doi: 10.1016/S0140-6736(22)00462-7.

A. Post and R. Lorenzo-Redondo, “Omicron: fewer adverse outcomes come with new dangers,” The Lancet, vol. 399, no. 10332, pp. 1280–1281, Apr. 2022, doi: 10.1016/S0140-6736(22)00514-1.

Yek, S. Warner, A. Mancera, and S. S. Kadri, “Misclassification bias in estimating clinical severity of SARS-CoV-2 variants,” The Lancet, vol. 400, no. 10355, p. 809, Sep. 2022, doi: 10.1016/S0140-6736(22)01469-6.

Juyal, A. Kumar, S. Pal, S. Thaledi et al., “Medical certification of cause of death during COVID-19 pandemic – a challenging scenario,” J Family Med Prim Care, vol. 9, no. 12, p. 5896, 2020, doi: 10.4103/JFMPC.JFMPC_1435_20.

Poulos, L. Zhu, and A. D. Shah, “Data gaps in electronic health record (EHR) systems: An audit of problem list completeness during the COVID-19 pandemic,” Int J Med Inform, vol. 150, p. 104452, Jun. 2021, doi: 10.1016/J.IJMEDINF.2021.104452.

Mwananyanda, C. J. Gill, W. MacLeod, G. Kwenda et al., “Covid-19 deaths in Africa: prospective systematic postmortem surveillance study,” BMJ, vol. 372, Feb. 2021, doi: 10.1136/BMJ.N334.

Gundlapalli, A. M. Lavery, T. G. Boehmer, M.J. Beach et al., “Death Certificate–Based ICD-10 Diagnosis Codes for COVID-19 Mortality Surveillance — United States, January–December 2020,” MMWR Morb Mortal Wkly Rep, vol. 70, no. 14, pp. 523–527, 2021, doi: 10.15585/MMWR.MM7014E2.

P. Walkowiak and D. Walkowiak, “Underestimation in Reporting Excess COVID-19 Death Data in Poland during the First Three Pandemic Waves,” Int J Environ Res Public Health, vol. 19, no. 6, Mar. 2022, doi: 10.3390/IJERPH19063692.

Ju and M. You, “It’s Politics, Isn’t It? Investigating Direct and Indirect Influences of Political Orientation on Risk Perception of COVID-19,” Risk Anal, vol. 42, no. 1, pp. 56–68, Jan. 2022, doi: 10.1111/RISA.13801.

T. Paul, J. M. Eberl, and J. Partheymüller, “Policy-Relevant Attitudes Toward COVID-19 Vaccination: Associations With Demography, Health Risk, and Social and Political Factors,” Front Public Health, vol. 9, Jul. 2021, doi: 10.3389/fpubh.2021.671896.

Albrecht, “Vaccination, politics and COVID-19 impacts,” BMC Public Health, vol. 22, no. 1, Dec. 2022, doi: 10.1186/S12889-021-12432-X.

Kerr, C. Panagopoulos, and S. van der Linden, “Political polarization on COVID-19 pandemic response in the United States,” Pers Individ Dif, vol. 179, Sep. 2021, doi: 10.1016/J.PAID.2021.110892.

Parker and D. Ferraz, “Politics and pandemics,” 10.1080/17441692.2021.1947601, vol. 16, no. 8–9, pp. 1131–1140, 2021, doi: 10.1080/17441692.2021.1947601.

M. da Fonseca, N. Nattrass, L. L. B. Lazaro, and F. I. Bastos, “Political discourse, denialism and leadership failure in Brazil’s response to COVID-19,” 10.1080/17441692.2021.1945123, vol. 16, no. 8–9, pp. 1251–1266, 2021, doi: 10.1080/17441692.2021.1945123.

Ortega and M. Orsini, “Governing COVID-19 without government in Brazil: Ignorance, neoliberal authoritarianism, and the collapse of public health leadership,” Glob Public Health, pp. 1257–1277, 2020, doi: 10.1080/17441692.2020.1795223.

Crabu, P. Giardullo, A. Sciandra, and F. Neresini, “Politics overwhelms science in the Covid-19 pandemic: Evidence from the whole coverage of the Italian quality newspapers,” PLoS One, vol. 16, no. 5, May 2021, doi: 10.1371/JOURNAL.PONE.0252034.

Sazzad, V. P. Rajan, and M. A. Demircioglu, “The Role of Leadership in Public Sector Innovation: A Systematic Review and Meta-Analysis of the Management of COVID-19 in Asian Countries,” Front Public Health, vol. 9, p. 743748, Dec. 2021, doi: 10.3389/FPUBH.2021.743748.

Talic, S. Shah, H. Wild, D.Gasevic et al., “Effectiveness of public health measures in reducing the incidence of covid-19, SARSCoV-2 transmission, and covid-19 mortality: Systematic review and meta-analysis,” The BMJ, vol. 375, Nov. 2021, doi: 10.1136/BMJ-2021-068302.

Flaxman, S. Mishra, A. Gandy, H. J. T. Unwin et al., “Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe,” Nature, vol. 584, no. 7820, pp. 257–261, Aug. 2020, doi: 10.1038/S41586-020-2405-7.

Zhou, T. J. Hu, X. Y. Zhang, K. Lai et al., “The association of intensity and duration of non-pharmacological interventions and implementation of vaccination with COVID-19 infection, death, and excess mortality: Natural experiment in 22 European countries,” J Infect Public Health, vol. 15, no. 5, pp. 499–507, May 2022, doi: 10.1016/J.JIPH.2022.03.011.

Schwarz, F. Mahfoud, L. Lauder, W. Reith et al., “Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19,” Clin Res Cardiol, vol. 109, no. 12, pp. 1500–1506, Dec. 2020, doi: 10.1007/S00392-020-01688-9.

Seiffert, F. J. Brunner, M. Remmel, G. Thomalla et al., “Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims,” Clinical Research in Cardiology, vol. 109, no. 12, pp. 1540–1548, Dec. 2020, doi: 10.1007/s00392-020-01723-9.

[67] A. K. Gitt, A. K. Karcher, R. Zahn, and U. Zeymer, “Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissions,” Clinical Research in Cardiology, vol. 109, no. 12, pp. 1585–1587, Dec. 2020, doi: 10.1007/s00392-020-01705-x.

Thornton, “Covid-19: A&E visits in England fall by 25% in week after lockdown,” BMJ, vol. 369, p. m1401, Apr. 2020, doi: 10.1136/BMJ.M1401.

Kondilis, F. Tarantilis, and A. Benos, “Essential public healthcare services utilization and excess non-COVID-19 mortality in Greece,” Public Health, vol. 198, pp. 85–88, Sep. 2021, doi: 10.1016/J.PUHE.2021.06.025.

É. Czeisler, K. Marynak, K. E.N. Clarke, Z.Salah et al., “Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns – United States, June 2020,” MMWR Morb Mortal Wkly Rep, vol. 69, no. 36, pp. 1250–1257, Sep. 2020, doi: 10.15585/MMWR.MM6936A4.

Zumla, J. Chakaya, M. Khan, R.Fatima et al., “World Tuberculosis Day 2021 Theme – ‘The Clock is Ticking’ – and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic,” International Journal of Infectious Diseases, vol. 113, pp. S1–S6, Dec. 2021, doi: 10.1016/j.ijid.2021.03.046.

World Health Organization, “Annual Report of Tuberculosis,” Annual Global TB Report of WHO, vol. 8, no. 1, pp. 1–68, 2022, Accessed: May 15, 2023. [Online]. Available: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022%0A    

Dinmohamed, O. Visser, R. H. A. Verhoeven, M. V. J. Louwman et al., “Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands,” Lancet Oncol, vol. 21, no. 6, pp. 750–751, Jun. 2020, doi: 10.1016/S1470-2045(20)30265-5.

Schrag, D. L. Hershman, and E. Basch, “Oncology Practice during the COVID-19 Pandemic,” JAMA – Journal of the American Medical Association, vol. 323, no. 20, pp. 2005–2006, May 2020, doi: 10.1001/JAMA.2020.6236.

Bu, “The impact of COVID-19 on Australian cancer screening and strategies to mitigate ongoing disruption of screening services,” Aust J Gen Pract, vol. 50, pp. 1–2, 2021, doi: 10.31128/AJGP-COVID-50.

Teglia, M. Angelini, L. Astolfi, G. Casolari et al., “Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis,” JAMA Oncol, vol. 8, no. 9, pp. 1287–1293, Sep. 2022, doi: 10.1001/JAMAONCOL.2022.2617.

Teglia, M. Angelini, G. Casolari, L. Astolfi et al., “Global Association of COVID-19 Pandemic Measures with Cancer Treatment: A Systematic Review and Meta-Analysis.,” Cancers (Basel), vol. 14, no. 22, Nov. 2022, doi: 10.3390/cancers14225490.

Causey, N. Fullman, R. J. D. Sorensen, N. C. Galles et al., “Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study,” The Lancet, vol. 398, no. 10299, pp. 522–534, Aug. 2021, doi:10.1016/S0140-6736(21)01337-4.

Kumari, K. Mehta, and R. Choudhary, “COVID-19 outbreak and decreased hospitalisation of pregnant women in labour,” Lancet Glob Health, vol. 8, no. 9, pp. e1116–e1117, Sep. 2020, doi: 10.1016/S2214-109X(20)30319-3.

N. Ezenwa, I. B. Fajolu, H. Nabwera, D. Wang, et al., “Impact of COVID-19 lockdown measures on institutional delivery, neonatal admissions and prematurity: a reflection from Lagos, Nigeria,” BMJ Paediatr Open, vol. 5, no. 1, Apr. 2021, doi: 10.1136/BMJPO-2021-001029.

Alicandro, G. Remuzzi, and C. La Vecchia, “Italy’s first wave of the COVID-19 pandemic has ended: no excess mortality in May, 2020,” Lancet, vol. 396, no. 10253, p. e27, Sep. 2020, doi: 10.1016/S0140-6736(20)31865-1.

Kontopantelis, M. A. Mamas, J. Deanfield, M. Asaria et al., “Excess mortality in England and Wales during the first wave of the COVID-19 pandemic,” J Epidemiol Community Health (1978), vol. 75, no. 3, pp. 213–223, Mar. 2021, doi: 10.1136/JECH-2020-214764.

Barański, G. Brożek, M. Kowalska, A. Kaleta-Pilarska et al., “Impact of COVID-19 Pandemic on Total Mortality in Poland,” Int J Environ Res Public Health, vol. 18, no. 8, Apr. 2021, doi: 10.3390/IJERPH18084388.

John, J. Pirkis, D. Gunnell, L. Appleby et al., “Trends in suicide during the covid-19 pandemic,” BMJ, vol. 371, Nov. 2020, doi: 10.1136/BMJ.M4352.

Rezaeiahari and B. J. Fairman, “Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas,” Int J Drug Policy, vol. 109, p. 103836, Nov. 2022, doi: 10.1016/J.DRUGPO.2022.103836.

“Overdose Deaths Accelerating During COVID-19 | CDC Online Newsroom | CDC.” https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html (accessed May 15, 2023).

Gunnell, L. Appleby, E. Arensman, K. Hawton et al., “Suicide risk and prevention during the COVID-19 pandemic,” Lancet Psychiatry, vol. 7, no. 6, pp. 468–471, Jun. 2020, doi: 10.1016/S2215-0366(20)30171-1.

Wasserman, “The Impact of Epidemic, War, Prohibition and Media on Suicide: United States, 1910–1920,” Suicide Life Threat Behav, vol. 22, no. 2, pp. 240–254, Jun. 1992, doi: 10.1111/J.1943-278X.1992.TB00231.X.

T. Cheung, P. H. Chau, and P. S. F. Yip, “A revisit on older adults suicides and Severe Acute Respiratory Syndrome (SARS) epidemic in Hong Kong,” Int J Geriatr Psychiatry, vol. 23, no. 12, pp. 1231–1238, 2008, doi: 10.1002/GPS.2056.

M. S. Chan, F. K. H. Chiu, C. W. L. Lam, P. Y. V. Leung et al., “Elderly suicide and the 2003 SARS epidemic in Hong Kong,” Int J Geriatr Psychiatry, vol. 21, no. 2, pp. 113–118, Feb. 2006, doi: 10.1002/gps.1432.

J. Yasin, M. Grivna, and F. M. Abu-Zidan, “Global impact of COVID-19 pandemic on road traffic collisions,” World Journal of Emergency Surgery, vol. 16, no. 1, pp. 1–14, Dec. 2021, doi: 10.1186/S13017-021-00395-8/TABLES/2.

Parr, B. Wolshon, J. Renne, P. Murray-Tuite, et al., “Traffic impacts of the COVID-19 pandemic: statewide analysis of social separation and activity restriction,” Nat Hazards Rev, vol. 21, no. 3, p. 04020025, Aug. 2020, doi: 10.1061/(asce)nh.1527-6996.0000409.

C. Ramírez-Soto and G. Ortega-Cáceres, “Analysis of Excess All-Cause Mortality and COVID-19 Mortality in Peru: Observational Study,” Trop Med Infect Dis, vol. 7, no. 3, Mar. 2022, doi: 10.3390/TROPICALMED7030044.

Tempia, S. Walaza, J. N. Bhiman, M. L. McMorrow et al., “Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020,” Euro Surveill, vol. 26, no. 29, Jul. 2021, doi: 10.2807/1560-7917.ES.2021.26.29.2001600.

H. Kim, Y. H. Roh, J. G. Ahn, M. Y. K. RN et al., “Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19,” Int J Infect Dis, vol. 110, pp. 29–35, Sep. 2021, doi: 10.1016/J.IJID.2021.07.005.

Spantideas, A. M. Bougea, E. G. Drosou, N. Khanderia et al., “COVID-19 and Seasonal Influenza: No Room for Two,” Cureus, vol. 13, no. 9, Sep. 2021, doi: 10.7759/CUREUS.18007.

Mirza, M. Mirza “Lessons Learned From the COVID-19 Pandemic: Factors Affecting Decreased Incidence of Influenza – PubMed.” https://pubmed.ncbi.nlm.nih.gov/36940124/(accessed May 14, 2023).

Rana, M. William, A. Kewalramani, J. Daloya et al., “COVID-19 Mask Mandates in NY and Their Effect on the Incidence of Flu,” J Community Hosp Intern Med Perspect, vol. 13, no. 1, Jan. 2023, doi: 10.55729/2000-9666.1140.

W. S. Ko, L. H. S. Lau, S. S. Ng, T. Ch. F. Yip et al., “Respiratory admissions before and during the COVID-19 pandemic with mediation analysis of air pollutants, mask-wearing and influenza rates,” Respirology, vol. 28, no. 1, pp. 47–55, Jan. 2023, doi: 10.1111/RESP.14345.

Horita and T. Fukumoto, “Two years of the pandemic suppressed deaths from non-COVID-19 respiratory infections: A nationwide surveillance in Japan,” Respirology, vol. 28, no. 1, pp. 82–83, Jan. 2023, doi: 10.1111/resp.14392.

V. W. de Vries and L. Rambabu, “The impact of natural disasters on the spread of COVID-19: a geospatial, agent-based epidemiology model,” Theor Biol Med Model, vol. 18, no. 1, pp. 1–9, Dec. 2021, doi: 10.1186/S12976-021-00151-0/FIGURES/4.

C. Quigley, J. Attanayake, A. King, and F. Prideaux, “A multi-hazards earth science perspective on the COVID-19 pandemic: the potential for concurrent and cascading crises,” Environ Syst Decis, vol. 40, no. 2, p. 199, Jun. 2020, doi: 10.1007/S10669-020-09772-1.

A. Phillips, A. Caldas, R. Cleetus, K. A. Dahl et al., “Compound climate risks in the COVID-19 pandemic,” Nature Climate Change 2020 10:7, vol. 10, no. 7, pp. 586–588, May 2020, doi: 10.1038/s41558-020-0804-2.

E. Kruk, A. D. Gage, N. T. Joseph, G. Danaei et al., “Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries,” The Lancet, vol. 392, no. 10160, pp. 2203–2212, Nov. 2018, doi: 10.1016/S0140-6736(18)31668-4.

R. Wells and A. P. Galvani, “The global impact of disproportionate vaccination coverage on COVID-19 mortality,” Lancet Infect Dis, vol. 22, no. 9, pp. 1254–1255, Sep. 2022, doi: 10.1016/S1473-3099(22)00417-0.

G. T. Walker, Ch. Whittaker, O. J. Watson, M. Baguelin et al., “The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries,” Science, vol. 369, no. 6502, pp. 413–422, Jul. 2020, doi: 10.1126/SCIENCE.ABC0035.

Rios, E. Denova-Gutierrez, and S. Barquera, “Association between living in municipalities with high crowding conditions and poverty and mortality from COVID-19 in Mexico,” PLoS One, vol. 17, no. 2 Febuary, Feb. 2022, doi: 10.1371/journal.pone.0264137.

E. Antonio-Villa, L. Fernandez-Chirino, J. Pisanty-Alatorre, J. Mancilla-Galindo et al., “Comprehensive Evaluation of the Impact of Sociodemographic Inequalities on Adverse Outcomes and Excess Mortality During the Coronavirus Disease 2019 (COVID-19) Pandemic in Mexico City,” Clin Infect Dis, vol. 74, no. 5, pp. 785–792, Mar. 2022, doi: 10.1093/CID/CIAB577.

Jefferies, N. French, Ch. Gilkison, G. Graham et al., “COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study,” Lancet Public Health, vol. 5, no. 11, pp. e612–e623, Nov. 2020, doi: 10.1016/S2468-2667(20)30225-5.

Stobart and S. Duckett, “Australia’s Response to COVID-19,” Health Econ Policy Law, vol. 17, no. 1, pp. 95–106, Jan. 2022, doi: 10.1017/S1744133121000244.

M. McMichael, S. Clark, S. Pogosjans, M. Kay et al., “COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020,” Morbidity and Mortality Weekly Report, vol. 69, no. 12, p. 339, Mar. 2020, doi: 10.15585/MMWR.MM6912E1.

He, Y. Li, and F. Fang, “Is There a Link between Nursing Home Reported Quality and COVID-19 Cases? Evidence from California Skilled Nursing Facilities,” J Am Med Dir Assoc, vol. 21, no. 7, pp. 905–908, Jul. 2020, doi: 10.1016/j.jamda.2020.06.016.

T. Konetzka, E. M. White, A. Pralea, D. C. Grabowski et al., “A systematic review of long-term care facility characteristics associated with COVID-19 outcomes,” J Am Geriatr Soc, vol. 69, no. 10, pp. 2766–2777, Oct. 2021, doi: 10.1111/JGS.17434.

Sempé, P. Lloyd-Sherlock, R. Martínez, S. Ebrahim et al., “Estimation of all-cause excess mortality by age-specific mortality patterns for countries with incomplete vital statistics: a population-based study of the case of Peru during the first wave of the COVID-19 pandemic,” The Lancet Regional Health – Americas, vol. 2, Oct. 2021, doi: 10.1016/j.lana.2021.100039.

A. Sinnathamby, H. Whitaker, L. Coughlan, J. L. Bernal et al., “All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England,” Euro Surveill, vol. 25, no. 28, Jul. 2020, doi: 10.2807/1560-7917.ES.2020.25.28.2001239.

Cobos-Siles, P. Cubero-Morais, I. Arroyo-Jimenez, M. Rey-Hernandez et al., “Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events,” Intern Emerg Med, vol. 15, no. 8, p. 1533, Nov. 2020, doi: 10.1007/S11739-020-02485-Y.